MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Identification of aberrant circulating miRNAs in Parkinson’s disease plasma samples

L. Chen, J. Yang (Tianjin, China)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Identification of candidates for device-assisted therapy in Parkinson’s disease using Artificial Neural Networks

C. Valderrama Martín, L. Triguero Cueva, MJ. Pérez Navarro, CJ. Madrid Navarro, R. Calle Calle, I. Rego García, A. Mínguez Castellanos, IM. Galván León, F. Escamilla Sevilla (Granada, Spain)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India

D. Venkatesan, B. Vellingiri (Coimbatore, India)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Identification of modifier genes related to G proteins pathways on the motor capacity of a Drosophila melanogaster model of Friedreich’s ataxia

EG. Zucchet, J. Gonzalez, P. Calap, P. Gonzalez Cabo, MD. Moltó Ruiz (Valencia, Spain)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Identifying In-Clinic Wearable Sensor Features that Predict Parkinson’s Disease Severity

A. Dowling, A. Mirelman, J. Hausdorff, M. Sela, O. Assais, N. Giladi, J. Cedarbaum (Cambridge, MA, USA)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Identifying the association of depression and distress in Pakistani patients diagnosed with Parkinsonism syndrome

A. Fatima (Lahore, Pakistan)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Imaging Parkinson’s disease pathology: A comparison between neuromelanin-sensitive MRI, susceptibility weighted imaging and [11C]PE2I DAT PET

A. Chandra, G. Pagano, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

Neuroanatomy  ·  Les Muses, Level 3
1:45pm-3:15pm
Immediate effect of the virtual and augmented reality and neurofunctional physiotherapy on postural control and cognition in patients with Parkinson’s disease: a randomized clinical trial

S. Smaili, H. Araújo, R. de Souza, T. da Silva, T. Nascimento, M. Terra (Londrina, Brazil)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Immediate Effects of Non-Motorized Treadmill Training for One Session on Gait and Fall Risk In Parkinson’s Disease

A. Boddy, K. Mitchell, W. Brewer, J. Ellison (St. Augustine, FL, USA)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Impact of caring for patients with Huntington’s disease on work status

K. Raimundo, R. Tan, T. To, J. de Courcy, U. Ondhia, H. Rickards, M. Nance (San Francisco, CA, USA)

Huntington’s Disease  ·  Agora 3 West, Level 3
  • «Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley